baber/WOPTO huggingface dataset:
Patent IL-68450-A0 (IL)
Title: Microbial polysaccharides,process for their preparation,microorganisms suitable for this and use of the polysaccharides
IPC: C12N1/20
Filed: 1983-04-21
Abstract: Polysaccharides are obtained by fermentation using a mixed culture of several microorganisms, of which at least one also produces a polysaccharide in pure culture, which polysaccharides are suitable as viscosity regulators. A mixed culture of the strains Pseudomonas maltophilia DSM 2130 and Agrobacterium tumefaciens DSM 2128 is particularly suitable.
Patent IL-75424-A0 (IL)
Title: Process for the isolation and purification of alpha-interferons
IPC: C07K1/22
Filed: 1985-06-06
Abstract: The invention relates to a process for the isolation and purification of  alpha -interferons generated by plasmids from bacterial cultures which have been modified by genetic engineering, and of  alpha -interferons from culture supernatants of induced mammalian cells, which comprises partition of appropriate crude substances containing interferon between an aqueous urea solution, which contains a surfactant, and a mixture of n-butanol and glacial acetic acid which contains water, and isolation of the purified  alpha -interferons from the upper phase.
Patent IL-81196-A0 (IL)
Title: Magnetic alloys
IPC: H01F1/04
Filed: 1987-01-08
Abstract: Disclosed is a interacting hard magnetic material. The material consists essentially of a solid mass or assembly of crystallites. Each crystallite has an easy axis of magnetization, e.g., to allow for magnetic orientation within the crystallite. Each of these crystallites are crystallographically non-oriented with adjacent crystallites, which they meet at grain boundaries. The grain boundaries are narrow enough to allow ferromagnetic interaction between adjacent crystallites.
Patent IL-81514-A0 (IL)
Title: Contact-breaking ignition plug and method of generating a spark therewith
IPC: H01T13/40
Filed: 1987-02-09
Abstract: A contact-breaking ignition plug comprises a magnet coil arranged in a housing and surrounding a magnet core. The magnet core comprises an enlarged end portion with lateral surfaces extending conically in relation thereto and also comprises a cavity in which an armature is movably arranged. The armature is mounted on a rod in asymmetrical relation to a longitudinal center plane of the cavity and in transverse relation to the direction of compression pressure propagation. These features induce a concentration of the magnetic effect in the armature region and cause the contact-breaking motion to be augmented by the compression pressure. Respective contact electrodes are exchangeably mounted at each of the free end of the armature and a nose of the housing. The contact electrodes are mounted such that an electrical ignition pulse traversing a short-circuit path extending from the magnet coil of the electromagnet through the contact electrodes induces a magnetic field in the electromagnet, leading to interruption of the short-circuit path and the formation of a spark. The interruption sequence can be accelerated by means of this contact-breaking ignition plug and can be more precisely controlled and material deformations no longer arise during the contact-breaking motions.
Patent IL-89126-A0 (IL)
Title: Beta-lactam antibiotics,their preparation and pharmaceutical compositions containing them
IPC: C07D471/04
Filed: 1989-01-31
Abstract: Hetero-fused phenylglycine- beta -lactam antibiotics of the formula (I) 
<IMAGE>
 in which R<1> represents a hetero-fused radical, process for their preparation and their use as therapeutic agents and in therapeutic agents, in particular as antibacterial, orally active antibiotics.
Patent IL-93361-A0 (IL)
Title: Cross-linked antibodies
IPC: C07K1/113
Filed: 1990-02-12
Abstract: Cross-linked antibody conjugates are described which have at least one interchain bridge containing a reporter or effector molecule. The bridge may be the residue of a homo- or hereofunctional cross-linking reagent, and is located away from the antigen binding domains of the antibody. The antibody conjugates have an enhanced binding capacity and in vivo have good blood clearance and, in the presence of a tumour high tumour: blood and tumour: bone ratios. The conjugates are of use in the diagnosis and therapy of e.g. tumours and may be prepared by reaction of a cross-linking reagent with an antibody.
Patent IL-94099-A0 (IL)
Title: Radial type of parallel system bus structure
IPC: G06F13/40
Filed: 1990-04-18
Abstract: Disclosed is an improved parallel system bus structure comprising a plurality of bus wire-printed disks (5) each having a plurality of signal conductors (6) of equal length extending radially from a common central contact (7). These bus disks (5) are spaced vertically at regular intervals, and a plurality of connectors (12) are fixed to the circumference of the bus disks to permit connection between the signal conductors of the bus disks and the terminals of the CPU board. The radial arrangement of signal conductors (6) permits connection of selected CPU boards via equal length signal paths, no matter how many CPU boards may be used.
Patent IL-95951-A0 (IL)
Title: Categorization automata employing neuronal group selection with reentry
IPC: G06F15/18
Filed: 1990-10-10
Abstract: An apparatus capable of sensing the presence of objects in its environment, categorizing these objects without a prior description of the categories to be expected, and controlling robotic effector mechanisms to respond differentially to such objects according to their categories. Such responses include sorting objects, rejecting objects of certain types, and detecting novel or deviant objects. The invention includes a device called a "classification n-tuple" (of which a "classification couple" is a special case) capable of combining signals from two or more sensory modalities to arrive at the classification of the object. The invention operates by simulating certain features of animal nervous system, including neurons with responses determined at each moment of time by inputs received along synaptic connections from sensory means or form other neurons. In this invention, neurons are arranged in "groups", which permits them to act cooperatively while still retaining characteristic individual responses. Groups in turn are arranged in "repertoires", which provide a totality of response specificities sufficient to respond to any of a range of possible input objects. Some of these repertoires are organized as "maps", such that groups responding to inputs that are similar along some dimensional (spatial or abstract) are close together in the repertoire, enabling the repertoire to respond correctly to novel objects that are similar to objects it has encountered previously. Maps in this invention are linked by connections, called "reentrant" connections, that enable the responses of one map to be reentered into the system as inputs to another map. Reentrant connections permit signals from different sensory modalities to be correlated in an ongoing fashion, and they are the basis for the operation of classification n-tuples. The responses of the apparatus of this invention may be improved and optimized for a particular task through the operation of "neuronal group selection", a process which enhances the responses of those neuronal groups in the apparatus which were active in some time interval preceding the production of a useful output action. This process operates by modifying the strength of selected synaptic connections. The value of various output actions is determined, for the purpose of regulating selection, by means which are internal to the apparatus of this invention. Accordingly, the invention is capable of self-organization and learning, and does not require a predetermined specification of correct responses for all possible inputs.
Patent IL-97693-A0 (IL)
Title: Preparation of piroxicam/cyclodextrin complexes,the products obtained and pharmaceutical compositions containing them
IPC: A61K31/724
Filed: 1991-03-27
Abstract: A process for preparing complexes of piroxicam with cyclodextrins in which the two components in the powder state are premixed and then co-ground in a high energy mill in the presence of steam. The products obtained have technological, physical and biopharmacological characteristics which are advantageous compared with those of liquid-state complexes obtained by traditional methods, and are suitable for preparing pharmaceutical compositions for oral, rectal and topical use.
Patent FI-20106117-A0 (FI)
IPC: B65G/
Filed: 2010-10-27
Abstract: A cover and frame assembly for a discharge end of a belt conveyor, the assembly including: a stationary frame supporting the discharge end and including sides extending beyond the discharge end; a cover having a top, opposite side walls extending down from the top and an end face extending between the side walls and down from the top; a rim along each of the side walls, wherein each the rim seats on an upper edge of one of the sides of the stationary frame, while the cover is closed over the discharge end, and a roller on each upper edge of the sides of the stationary frame, wherein each roller extends above the upper edge and seats in a hole or pit in the rim seated on the upper edge while the cover is closed, wherein the rim of each side wall slides over the corresponding roller as the cover is opened.
Patent IL-102570-A0 (IL)
Title: Aminocarboxylate ligands having substituted aromatic amide moieties and diagnostic agents containing the same
IPC: C07D257/02
Filed: 1992-07-21
Abstract: Novel metal-chelate complexes comprising aminocarboxylate ligands including substituted aromatic amide moieties, such as those having the formula <CHEM> wherein R13, A1, R1 and R2 are as defined herein, are disclosed.
Patent IL-108705-A0 (IL)
Title: Pharmaceutical compositions containing bisacodyl in dosage form
IPC: A61K9/22
Filed: 1994-02-18
Abstract: The subject invention involves pharmaceutical compositions in dosage unit form, for peroral administration of bisacodyl to a human or lower animal having a gastrointestinal tract, with a lumen therethrough, with a small intestine and a colon with a junction therebetween, comprising: (a) a safe and effective amount of rapidly-dissolving bisacodyl means; and (b) a delivery means which prevents the release of bisacodyl from the dosage form into the lumen of the gastrointestinal tract during transport of the dosage form through the lumen until the dosage form is near the junction between the small intestine and the colon or in the colon, and which then releases the bisacodyl in the lumen near the junction between the small intestine and the colon or within the colon, The subject invention also involves methods for providing laxation for humans and lower animals in need thereof by peroral administration of such compositions.
Patent IL-111451-A0 (IL)
Title: A variable block size adaptation algorithm for noise-robust acoustic echo cancellation
IPC: H03H21/00
Filed: 1994-10-30
Abstract: An apparatus that automatically adjusts the adaptation block size for a least-mean square (LMS) adaptive filter depending on the input signal-to-noise ratio (SNR) is disclosed. The apparatus monitors the instantaneous SNR and continually adjusts the block size to provide high noise immunity, thereby increasing the convergence speed of the filter and decreasing the asymptotic mean-square error. An exemplary embodiment of the present invention is presented in the context of acoustic echo cancellation, though it is noted that the adaptive filter of the present invention is useful in any environment in which the noise characteristics are subject to change.
Patent IL-112487-A0 (IL)
Title: Method and apparatus for providing a communication link quality indication
IPC: H04L27/30
Filed: 1995-01-31
Abstract: A link quality improvement system for a cellular communication system in which portable units are used to facilitate communication of information signals between system users, via at least one cell-site, using code division multiple access spread spectrum communication signals. The system enables users to improve the quality of reverse communication links from the portable units to the cell-site by providing to each system user a link quality signal indicative of power received at the cell-site relative to an optimum level of received power. At a cell-site communicating with a portable unit associated with a particular system user, the portable unit transmitted power is measured as received at the cell-site. A command signal is generated at the cell-site and transmitted to the portable unit for adjusting portable unit transmitter power. The command signals are also accumulated in order to enable generation of a link quality signal in response thereto. In a preferred implementation the link quality signal is an audible interference signal inducing the system user to adjust orientation of the portable communication unit so as to improve signal quality on the reverse link.
Patent IL-113019-A0 (IL)
Title: Closure device for a conveying unit operating in a vacuum
IPC: B65G53/60
Filed: 1995-03-16
Abstract: The freely movable body consists of a ball (6) which is positioned beneath the funnel-shaped or point-symmetrical outlet (3). The ball stands on a support, in an open position, and closes the outlet opening (4) as a result of vacuum when conveying the pourable material. The ball is self-centering on the support and forms an annular outlet cross-section broken only by the struts of the support. The closure piece is made of the same material as the pourable material being conveyed.
Patent IL-114026-A0 (IL)
Title: 4-aryl-1-(indanmethyl dihydrobenzo furanmethyl or dihydrobenzo thiophenemethyl) piperidines tetrahydropyridines or piperazines
IPC: A61K31/496
Filed: 1995-06-07
Abstract: 4-Aryl-<bold>1</highlight>-(indanmethyl, dibydrobenzofuramethyl or dihydrobenzotbiophenemethyl) piperidine, -tetrabydropyridine or -piperazine compounds of general formula (I) wherein one of X and Y is CH<subscript>2</highlight>, and the other one is CH<subscript>2</highlight>, O or S; Z is N, C, CH or COH; Ar is an optionally substituted aryl group; R<superscript>1 >is hydrogen, alkyl, cycloalkyl, cycloakylalkyl, aryl, arylalkyl, acyl, thioacyl, alkylsulfonyl, trifloromethylsulfonyl, arylsulfonyl, a group R<superscript>9>VCO- where V is O or S and R<superscript>9 >is alkyl or aryl, or a group R<superscript>10>R<superscript>11>NCO or R<superscript>10>R<superscript>11>NCS- wherein R<superscript>10 >and R<superscript>11 >are hydrogen, alkyl or aryl, or R<superscript>10 >and R<superscript>11 >are linked to form a ring R<superscript>2 >is hydrogen, alkyl, cycloalkyl or cycloalkylalkyl; or R<superscript>1 >and R<superscript>2 >are linked to form a ring; R<superscript>3>—R<superscript>5 >are hydrogen, halogen, alkyl, alkylcarbonyl, phenylcarbonyl, alkoxy, alkylthio, hydroxy, alkylsulfonyl, cyano, trifluoromethyl, cycloalkyl, cycloalkylaLkyl or nitro; R<superscript>6 >and R<superscript>7 >are bydrogen or alkyl or they are linked to constitute a 3-7-membered ring; R<superscript>8 >is hydrogen or alkyl; have effects at central serotonergic receptors and are therefore useful in the treatment of certain psychic and neurologic disorders.
Patent IL-116225-A0 (IL)
Title: Process and intermediates for the selective preparation of enantiomerically pure phenylsubstituted 1 4-dihydropyridine-3 5-dicarboxylic acid derivatives
IPC: C07D211/80
Filed: 1995-12-01
Abstract: 2-Benzylidene-3-oxo-butyric acid malimide esters(II), enantiomerically pure aminocrotonic acid malimide esters (IIIa) and enantiomerically pure acetoacetic acid malimide esters (VI) are new. Benzylidene compounds of formula (II), enantiomerically pure aminocrotonic acid esters of formula (IIIa) and enantiomerically pure acetoacetic acid esters of formula (VI) are new. [Image] R2>phenyl substituted by 1 or 2 of halo, CN, ethynyl, OCF3, SMe, NO2, CF3, 1-4C alkyl, 2-4C alkenyl, 2-4C alkynyl or 1-4C alkoxy; A : H or 1-8C alkyl; or phenyl or benzyl (both optionally substituted by 1-3 of OH, NO2, halo, CN, COOH, CF3, OCF3 or 1-6C alkoxy or by NR6>R7> or SO2R8>); R6>, R7>H, Ph or 1-5C alkyl; R8>1-4C alkyl or Ph. Independent claims are also included for: (1) the preparation of enatiomerically pure (II), (IIIa) and (VI); and (2) the preparation of diastereomeric 1,4-dihydropyridines of formula (IVa) or (IVb) by: (a) reacting enatiomerically pure (II) with aminocrotonic acid ester of formula Me-C(NH2)=CH-COOR1> (III) in a solvent, optionally in presence of base; or (b) reacting enatiomerically pure (IIIa) with benzylidene compound of formula R2>-CH=C(COMe)-COOR1> (IIa) in a solvent, optionally in presence of base. [Image] R1>1-8C alkyl (optionally substituted by 1-6C alkoxy) or 3-7C cycloalkyl.
Patent IL-122242-A0 (IL)
Title: Combination of angiotensin II receptor and epoxy-steroidal aldosterone receptor antagonist
IPC: C07D403/04
Filed: 1996-06-05
Abstract: A combination comprising therapeutically-effective amount of an epoxy-steroidal aldosterone receptor antagonist and a therapeutically-effective amount of an angiotensin II receptor antagonist is described for treatment of circulatory disorders.
Patent IL-127752-A0 (IL)
Title: New polycyclic phthalazine derivatives and their use
IPC: A61K31/50
Filed: 1997-07-09
Abstract: PCT No. PCT/FI96/03632 Sec. 371 Date Jan. 28, 2000 Sec. 102(e) Date Jan. 28, 2000 PCT Filed Jul. 9, 1997 PCT Pub. No. WO98/07706 PCT Pub. Date Feb. 26, 1998Polycyclic phthalazines, in particular 2-substituted maduraphthalazines (10,12,15,16-tetrahydroxy-8-methoxy-11-methyl-1,9,14-trioxo-1,2,6,7,9,14-hexahydronaphthaceno-1,2-g-phthalazines), of formula I and their use against gram-positive bacterial strains, particularly against multi-resistant staphylococci (MRSA) and against glycopeptide-resistant, for example vancomycin-resistant, enterococci. The polycyclic phthalazines are thus suitable for preparing anti-bacterially effective pharmaceutical compositions. In formula I, R1 is carboxyalkyl or carboxyaryl, and R2 and R3 represent H or acyl (for example CO-alkyl or COO-alkyl), with R1 being different from optionally substituted carboxyphenyl when R3 represents C1-8 alkanoyl. The invention also relates to salts, amides and esters of compounds of formula I.
Patent IL-127804-A0 (IL)
Title: A planar dual-frequency array antenna
IPC: H01Q/
Filed: 1996-07-04
Abstract: The antenna comprises two planar array layered antenna units, one operating in a low frequency band, the other operating in a high frequency band. The first antenna is the top unit and the second antenna is the bottom unit. The first unit has dielectric plates with front and rear faces, planar patch areas filled with conducting material on the face of a dielectric plate array, and a feed array, each having a feed connected to one of the array patches. Each patch resonates at the low frequencies and is transparent to the high frequencies, while a ground plane reflects low frequencies and is transparent to high frequencies. The second antenna is similarly constructed.
Patent IL-128160-A0 (IL)
Title: Purine derivatives and pharmaceutical compositions containing the same
IPC: C07D473/16
Filed: 1997-08-14
Abstract: This invention is directed to purine derivatives of the following formulae:    <IMAGE>  (I)   <IMAGE>  (II)   <IMAGE>  (III)   <IMAGE>  (IV)  wherein Z1 is -O-, -N(R10)- or -CH2O-; Z2 is -O-, -N(R10)- or -OCH2-; R1 and R4 are each independently hydrogen, halo, alkyl, -OR10, -C(O)OR10, -C(O)N(R10)R11, -N(R10)R11, -N(R10)C(O)R10, or -N(H)S(O)2R13; R2 is -C(NH)NH2, -C(NH)N(H)OR10, -C(NH)N(H)C(O)OR13, -C(NH)N(H)C(O)R10, -C(NH)N(H)S(O)2R13, or -C(NH)N(H)C(O)N(H)R10; R3 is halo, alkyl, haloalkyl, haloalkoxy, ureido, cyano, guanidino, -OR10, -C(NH)NH2, -C(NH)N(H)OR10, -C(O)N(R10)R11, -R12-C(O)N(R10)R11, -CH(OH)C(O)N(R10)R11, -N(R10)R11, -R12-N(R10)R11, -C(O)OR10, -R12-C(O)OR10, -N(R10)C(O)R10, (1,2)-tetrahydropyrimidinyl (optionally substituted by alkyl), (1,2)-imidazolyl (optionally substituted by alkyl), or (1,2)-imidazolinyl (optionally substituted by alkyl); R5 is hydrogen, halo, alkyl, cycloalkyl, haloakyl, aryl, aralkyl, alkylthio, hydroxy, mercapto, alkoxy, or -N(R10)R11; and R6 is defined herein. These compounds are useful as anti-coagulants. This invention is also directed to pharmaceutical compositions containing the compounds of the invention, and methods of using the compounds to treat disease-states characterized by thrombotic activity.
Patent IL-131146-A0 (IL)
Title: Procedure and machinery for the moulding of an assembled object
IPC: B29C45/04
Filed: 1998-01-28
Abstract: The invention concerns a procedure for sequential moulding of an assembled object and a machine for the performance of the procedure. The in at least two subsequent mouldings produced object is moulded in a mould with a usually stationary front part (1), a movable back part (2) and at least one turnable middle part (3). After the moulding of the first part of the object (5), the middle part (3) is turned at least once, preferably 180 degrees around an axis/axle (4) placed in a right angle to the moving direction between the front part and the back part, before the moulding of the following part of the object (10) takes place. In this way the first part of the object from the moulding at the front part (1) can be transported via the turnable middle part (3) to the back part (2), where the following moulding on the object can take place. As well as the injection and the cooling can take place in the front part and in the back at the same time, a lot of cycle time can be saved. In a special design the middle part (3) can be equipped with an insulation (11) in the middle which secures that between the front part (1) and the middle part (3) can be maintained a higher temperature than between the middle part and the back part (2). Hereby it is possible to mould together considerably different materials such as a thermo plastic material and an elastomer, a silicone, or metal and plastic. <IMAGE>
Patent IL-138335-A0 (IL)
Title: Device for separating from each other a plurality of articles which are in contact with each other
IPC: B65G47/252
Filed: 1999-03-11
Abstract: A description is given of a device for separating from each other a plurality of objects (R) which are adjacent to each other and are being fed in a direction of advance (F) along an advance path (21), comprising a member (37) which is rotatable about an axis of rotation (37A) and is positioned, with respect to the direction of advance, in such a way that it interferes with the articles (R) fed along said advance path. The peripheral velocity of said rotatable member at the point of contact between said member and said articles has a component substantially matching the direction of advance of the articles along said path.
Patent IL-140653-A0 (IL)
Title: Glial cell line-derived neurotrophic factor antibody
IPC: C12P21/02
Filed: 2000-12-31
Abstract: A novel neurotrophic factor referred to as glial derived neurotrophic factor (GDNF) has been identified and isolated from serum free growth conditioned medium of B49 glioblastoma cells. Rat and human genes encoding GDNF have been cloned and sequenced. A gene enconding GDNF has been subcloned into a vector, and the vector has been used to transform a host cell in order to produce biologically active GDNF in a recombinant DNA process. <IMAGE>
Patent IL-145333-A0 (IL)
Title: Dopant pastes for the production of p,p+and n, n+regions in semiconductors
IPC: H01L31/0288
Filed: 2000-02-29
Abstract: Doping paste contains: (a) one or more doping-active components; (b) a SiO 2 matrix; (c) a solvent; (d) an acid and water; and (e) additives such as thickeners or wetting agent. The whole composition has impurities in the form of metal ions in concentrations of less than 500 ppb, preferably less than 200 ppb.